Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $15.1B | $15.7B | $15.9B | $4B | $4.2B | |
| Gross Profit | $5.9B | $6.8B | $7B | $1.7B | $1.9B | |
| Operating Income | $2.1B | $2.5B | $2.8B | $707.2M | $787.5M | |
| EBITDA | $3B | $3.5B | $3.8B | $937.3M | $1B | |
| Diluted EPS | $4.30 | $7.13 | $6.95 | $2.58 | $2.05 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5B | $5.1B | $5.8B | $6.1B | $7.1B | |
| Total Assets | $17.9B | $21B | $21.9B | $22.1B | $23.9B | |
| Current Liabilities | $2.9B | $3.8B | $4.6B | $4.7B | $4.2B | |
| Total Liabilities | $11B | $13.9B | $14B | $13.5B | $14.1B | |
| Total Equity | $7B | $7.1B | $7.8B | $8.6B | $9.8B | |
| Total Debt | $6.2B | $8.3B | $9B | $8.2B | $8.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.4B | $2.9B | $2.6B | $786.7M | $791.3M | |
| Cash From Investing | -$852.5M | -$154.7M | -$1.4B | $639.1M | -$280.6M | |
| Cash From Financing | -$630.9M | -$2.5B | -$561.8M | -$548.3M | -$477.4M | |
| Free Cash Flow | $1.7B | $2B | $1.6B | $550.3M | $529.7M | |
Ecolab, Inc. engages in providing products and services in the field of water, hygiene, and energy. It operates through the following segments: Global Industrial, Global Institutional and Specialty, Global Healthcare and Life Sciences, Global Pest Elimination, and Corporate. The Global Industrial segment relates to water, food and beverage, paper, and downstream operating segments. The Global Institutional and Specialty segment refers to the institutional, specialty, and healthcare operating segments. The Global Healthcare and Life Sciences segment includes the healthcare and life sciences operations. The Global Pest Elimination segment provides services designed to detect, prevent and eliminate pests, such as rodents and insects, in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other. The company was founded by Merritt J. Osborn in 1923 and is headquartered in St. Paul, MN.
In the current month, ECL has received 11 Buy ratings 12 Hold ratings, and 0 Sell ratings. The ECL average analyst price target in the past 3 months is $292.15.
According to analysts, the consensus estimate is that Ecolab, Inc. share price will rise to $292.15 per share over the next 12 months.
Analysts are divided on their view about Ecolab, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ecolab, Inc. is a Sell and believe this share price will drop from its current level to $248.00.
The price target for Ecolab, Inc. over the next 1-year time period is forecast to be $292.15 according to 23 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 12 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Ecolab, Inc. is a Hold. 12 of 23 analysts rate the stock a Hold at this time.
You can purchase shares of Ecolab, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ecolab, Inc. shares.
Ecolab, Inc. was last trading at $265.63 per share. This represents the most recent stock quote for Ecolab, Inc.. Yesterday, Ecolab, Inc. closed at $265.58 per share.
In order to purchase Ecolab, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.